Nicholas Hoffman & Company, Llc. Astrazeneca PLC Transaction History

Nicholas Hoffman & Company, Llc.

$2.35 Billion
Q3 2024

A detailed history of Nicholas Hoffman & Company, Llc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Nicholas Hoffman & Company, Llc. holds 25,654 shares of AZN stock, worth $1.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

25,654

Previous 25,644 0.04%

Holding current value

$1.7 Million

Previous $2 Million 0.05%

% of portfolio

0.09%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$76.67 - $87.62 $766 - $876	10 Added 0.04%	25,654 $2 Million
Q2 2024 Aug 02, 2024	SELL	$66.81 - $80.83 $24,185 - $29,260	-362 Reduced 1.39%	25,644 $2 Million
Q1 2024 Apr 22, 2024	BUY	$61.03 - $69.57 $40,584 - $46,264	665 Added 2.62%	26,006 $1.76 Million
Q4 2023 Jan 31, 2024	BUY	$61.89 - $69.28 $29,397 - $32,908	475 Added 1.91%	25,341 $1.71 Million
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $45,135 - $49,903	696 Added 2.88%	24,866 $1.68 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $14,051 - $15,237	201 Added 0.84%	24,170 $1.73 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $884 - $1,002	14 Added 0.06%	23,969 $1.66 Million
Q3 2022 Nov 04, 2022	SELL	$53.02 - $135.75 $2,651 - $6,787	-50 Reduced 0.21%	23,955 $1.31 Million
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $32,355 - $38,842	-546 Reduced 2.22%	24,005 $1.59 Million
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $780 - $939	14 Added 0.06%	24,551 $1.63 Million
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $134,677 - $147,354	-2,424 Reduced 8.99%	24,537 $1.47 Million
Q1 2021 May 11, 2021	SELL	$47.16 - $54.44 $102,950 - $118,842	-2,183 Reduced 7.49%	26,961 $1.34 Million
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $48,520 - $58,020	1,000 Added 3.55%	29,144 $1.46 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $119,407 - $137,475	2,250 Added 8.69%	28,144 $1.54 Million
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $7,068 - $9,070	164 Added 0.64%	25,894 $1.37 Million
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $154,447 - $209,785	-4,087 Reduced 13.71%	25,730 $1.15 Million
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $77,311 - $87,620	1,927 Added 6.91%	29,817 $1.33 Million
Q2 2019 Aug 12, 2019	BUY	$37.28 - $41.68 $102,520 - $114,620	2,750 Added 10.94%	27,890 $1.15 Million
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $102,104 - $123,768	-2,877 Reduced 10.27%	25,140 $1.02 Million
Q4 2018 Feb 08, 2019	SELL	$36.86 - $41.49 $19,277 - $21,699	-523 Reduced 1.83%	28,017 $1.06 Million
Q2 2018 Aug 07, 2018	SELL	$34.55 - $37.05 $23,148 - $24,823	-670 Reduced 2.29%	28,540 $1 Million
Q1 2018 May 07, 2018	SELL	$32.97 - $36.63 $6,231 - $6,923	-189 Reduced 0.64%	29,210 $1.02 Million
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $10,251 - $12,036	-354 Reduced 1.19%	29,399 $996,000
Q2 2017 Aug 14, 2017	BUY	N/A	29,753	29,753 $1.01 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.

Account

Nicholas Hoffman & Company, Llc. Astrazeneca PLC Transaction History